Related Experiment Videos
Hydroxyurea-induced nail pigmentation in HIV patients
1Department of Genito-urinary Medicine, St George's Hospital, Tooting, London SW17 0QT, UK.
HIV Medicine
|December 12, 2001
Summary
Hydroxyurea (HU) can cause abnormal nail pigmentation in patients with HIV. This side effect may be linked to its use alongside anti-retroviral therapy.
Area of Science:
- Oncology
- Dermatology
- Infectious Diseases
Background:
- Hydroxyurea (HU) is a cytotoxic agent for myeloproliferative disorders.
- HU is now used as an adjunct in combination anti-retroviral therapy.
- Adverse dermatological effects of HU are known, but nail changes in HIV patients are less documented.
Purpose of the Study:
- To report and analyze abnormal nail pigmentation in HIV-seropositive patients receiving HU.
- To identify potential factors contributing to the development of this side effect.
Main Methods:
- Case series describing four HIV-seropositive patients.
- Clinical observation of nail pigmentation changes.
- Review of treatment regimens including HU and anti-retroviral therapy.
Main Results:
- Four HIV-positive patients developed abnormal nail pigmentation while on HU therapy.
- The pigmentation appeared as a notable change in nail color.
Conclusions:
- Hydroxyurea may induce nail pigmentation in HIV-seropositive individuals.
- Further investigation is needed to understand the mechanism and clinical significance of HU-induced nail changes in this population.